In addition, studies have found that SGLT2 is also expressed in the human retina, and it plays a crucial role in the prevention and treatment of diabetic retinopathy by improving pathogenic factors of diabetes, protecting the blood–retinal barrier (BRB), and preserving the optic nerve, among other mechanisms [220]. Here, SLC5A2 is linked to diabetes mellitus.